168 related articles for article (PubMed ID: 24532159)
21. Characterization of the IPEC-J2 MDR1 (iP-gp) cell line as a tool for identification of P-gp substrates.
Ozgür B; Saaby L; Langthaler K; Brodin B
Eur J Pharm Sci; 2018 Jan; 112():112-121. PubMed ID: 29146563
[TBL] [Abstract][Full Text] [Related]
22. Bidirectional transport of rhodamine 123 and Hoechst 33342, fluorescence probes of the binding sites on P-glycoprotein, across MDCK-MDR1 cell monolayers.
Tang F; Ouyang H; Yang JZ; Borchardt RT
J Pharm Sci; 2004 May; 93(5):1185-94. PubMed ID: 15067695
[TBL] [Abstract][Full Text] [Related]
23. Cloning and heterologous expression of the ovine (Ovis aries) P-glycoprotein (Mdr1) in Madin-Darby canine kidney (MDCK) cells.
Zahner D; Alber J; Petzinger E
J Vet Pharmacol Ther; 2010 Jun; 33(3):304-11. PubMed ID: 20557448
[TBL] [Abstract][Full Text] [Related]
24. Several major antiepileptic drugs are substrates for human P-glycoprotein.
Luna-Tortós C; Fedrowitz M; Löscher W
Neuropharmacology; 2008 Dec; 55(8):1364-75. PubMed ID: 18824002
[TBL] [Abstract][Full Text] [Related]
25. Modulation of the cellular accumulation and intracellular activity of daptomycin towards phagocytized Staphylococcus aureus by the P-glycoprotein (MDR1) efflux transporter in human THP-1 macrophages and madin-darby canine kidney cells.
Lemaire S; Van Bambeke F; Mingeot-Leclercq MP; Tulkens PM
Antimicrob Agents Chemother; 2007 Aug; 51(8):2748-57. PubMed ID: 17548493
[TBL] [Abstract][Full Text] [Related]
26. Potential role for human P-glycoprotein in the transport of lacosamide.
Zhang C; Chanteux H; Zuo Z; Kwan P; Baum L
Epilepsia; 2013 Jul; 54(7):1154-60. PubMed ID: 23551115
[TBL] [Abstract][Full Text] [Related]
27. Investigation of MDR1-overexpressing cell lines to derive a quantitative prediction approach for brain disposition using in vitro efflux activities.
Sato S; Tohyama K; Kosugi Y
Eur J Pharm Sci; 2020 Jan; 142():105119. PubMed ID: 31682973
[TBL] [Abstract][Full Text] [Related]
28. Hyperglycemia induced down-regulation of renal P-glycoprotein expression.
Yeh SY; Pan HJ; Lin CC; Kao YH; Chen YH; Lin CJ
Eur J Pharmacol; 2012 Sep; 690(1-3):42-50. PubMed ID: 22721613
[TBL] [Abstract][Full Text] [Related]
29. Retroviral transfection of Madin-Darby canine kidney cells with human MDR1 results in a major increase in globotriaosylceramide and 10(5)- to 10(6)-fold increased cell sensitivity to verocytotoxin. Role of p-glycoprotein in glycolipid synthesis.
Lala P; Ito S; Lingwood CA
J Biol Chem; 2000 Mar; 275(9):6246-51. PubMed ID: 10692420
[TBL] [Abstract][Full Text] [Related]
30. Transfected MDCK cell line with enhanced expression of CYP3A4 and P-glycoprotein as a model to study their role in drug transport and metabolism.
Kwatra D; Budda B; Vadlapudi AD; Vadlapatla RK; Pal D; Mitra AK
Mol Pharm; 2012 Jul; 9(7):1877-86. PubMed ID: 22676443
[TBL] [Abstract][Full Text] [Related]
31. Avermectin transepithelial transport in MDR1- and MRP-transfected canine kidney monolayers.
Brayden DJ; Griffin J
Vet Res Commun; 2008 Jan; 32(1):93-106. PubMed ID: 17578674
[TBL] [Abstract][Full Text] [Related]
32. Evaluation of the near infrared compound indocyanine green as a probe substrate of p-glycoprotein.
Portnoy E; Gurina M; Magdassi S; Eyal S
Mol Pharm; 2012 Dec; 9(12):3595-601. PubMed ID: 23098218
[TBL] [Abstract][Full Text] [Related]
33. In vitro p-glycoprotein inhibition assays for assessment of clinical drug interaction potential of new drug candidates: a recommendation for probe substrates.
Rautio J; Humphreys JE; Webster LO; Balakrishnan A; Keogh JP; Kunta JR; Serabjit-Singh CJ; Polli JW
Drug Metab Dispos; 2006 May; 34(5):786-92. PubMed ID: 16455806
[TBL] [Abstract][Full Text] [Related]
34. Validation of Human MDR1-MDCK and BCRP-MDCK Cell Lines to Improve the Prediction of Brain Penetration.
Feng B; West M; Patel NC; Wager T; Hou X; Johnson J; Tremaine L; Liras J
J Pharm Sci; 2019 Jul; 108(7):2476-2483. PubMed ID: 30794795
[TBL] [Abstract][Full Text] [Related]
35. Exposure to antiepileptic drugs does not alter the functionality of P-glycoprotein in brain capillary endothelial and kidney cell lines.
Ambroziak K; Kuteykin-Teplyakov K; Luna-Tórtos C; Al-Falah M; Fedrowitz M; Löscher W
Eur J Pharmacol; 2010 Feb; 628(1-3):57-66. PubMed ID: 19958760
[TBL] [Abstract][Full Text] [Related]
36. Evaluation of P-glycoprotein-mediated renal drug interactions in an MDR1-MDCK model.
Karyekar CS; Eddington ND; Garimella TS; Gubbins PO; Dowling TC
Pharmacotherapy; 2003 Apr; 23(4):436-42. PubMed ID: 12680473
[TBL] [Abstract][Full Text] [Related]
37. Isolation of MDCK cells with low expression of
Bokulić A; Padovan J; Stupin-Polančec D; Milić A
Acta Pharm; 2022 Jun; 72(2):275-288. PubMed ID: 36651516
[TBL] [Abstract][Full Text] [Related]
38. From bench to bedside: utilization of an in vitro model to predict potential drug-drug interactions in the kidney: the digoxin-mifepristone example.
Woodland C; Koren G; Ito S
J Clin Pharmacol; 2003 Jul; 43(7):743-50. PubMed ID: 12856388
[TBL] [Abstract][Full Text] [Related]
39. pH Dependent but not P-gp Dependent Bidirectional Transport Study of S-propranolol: The Importance of Passive Diffusion.
Zheng Y; Benet LZ; Okochi H; Chen X
Pharm Res; 2015 Aug; 32(8):2516-26. PubMed ID: 25690341
[TBL] [Abstract][Full Text] [Related]
40. Upregulation of the expression of endogenous Mdr1 P-glycoprotein enhances lipid translocation in MDCK cells transfected with human MRP2.
Raggers RJ; Vogels I; van Meer G
Histochem Cell Biol; 2002 Feb; 117(2):181-5. PubMed ID: 11935294
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
